ZS Associates, Inc.

What does ZS Associates own?

ZS owns the ZS brand and its proprietary software platforms including ZAIDYN and Javelin. It is a single-brand firm with no separately branded subsidiaries.

Is ZS publicly traded?

No. ZS Associates is a private partnership owned by its principals and has never been listed on a stock exchange.

Who founded ZS?

Northwestern University professors Andris Zoltners and Prabhakant Sinha founded the firm in 1983 around their sales force analytics research.

Where is ZS headquartered?

ZS is headquartered in Evanston, Illinois, USA, adjacent to the Northwestern University campus where it was founded.

How many brands does ZS own?

One. ZS operates a single masterbrand; its software products are platforms within the brand rather than separate brands.

Who owns ZS?

The firm's principals, its senior partners, own ZS. It has no outside investors, public shareholders, or parent company.

What is ZS's revenue?

Not publicly disclosed. Third-party estimates place annual revenue between roughly $1.6 billion and $2.7 billion.

Andris Zoltners and Prabhakant Sinha founded ZS in 1983 in Evanston, Illinois, next to the Northwestern University campus where both were marketing science professors at the Kellogg School. The firm grew directly out of their research: they had built some of the first computer-assisted sales territory alignment models and saw a commercial market for applying analytics to sales force design.

The firm's original market was pharmaceutical sales. Drug companies employed large field forces that needed to be sized, deployed, and paid, and ZS's quantitative methods made it the dominant provider of that work through the 1980s and 1990s. The pharma incumbency it built in those years remains the foundation of the business.

Through the 2000s and 2010s the firm broadened from sales force design into commercial strategy, marketing, customer analytics, and managed services, and built a large offshore delivery operation, principally in India. It expanded beyond life sciences into technology, financial services, private equity, and industrial clients, though pharma remains its largest vertical.

The firm shortened its brand to ZS in recent years as it pushed into software and AI-driven products alongside consulting. Its acquisition history is deliberately modest: it bought Medullan in 2021, bioinformatics firm Intomics in 2022, Trials.ai in 2023, Salesforce specialist Digital Additive in 2024, and Torrent Consulting in 2025, all targeted capability additions rather than a roll-up strategy.

By 2025 the firm reported more than 15,000 employees and more than 1,700 client organizations, with founders Zoltners and Sinha still associated as co-founders and Pratap Khedkar serving as CEO.

ZS appears regularly on consulting industry rankings, including Vault's annual firm lists and Great Place to Work certifications in several major offices. Its founders' academic research on sales force management is among the most cited work in marketing science, and the firm publishes an annual Business Responsibility and Impact Report documenting workforce and supplier metrics, including that 81 percent of staff reported pride in working at ZS in 2025.

ZS has a notably clean public record for a firm of its size. No major regulatory actions, disqualifying lawsuits, data scandals, or client misconduct findings are on record. The scrutiny it faces is the ordinary kind for large consultancies: questions over confidentiality and influence in regulated industries, and the demands of consulting work on employee wellbeing.

As a private partnership it is not subject to public company disclosure, so its record is less exposed than a listed firm's, but no significant legal or regulatory findings are attached to it.